ALASTIN Skincare, has appointed Ann Rhoads and Elisabeth Sandoval to the company's Board of Directors. Rhoads is a healthcare finance executive with more than 25 years of experience. Sandoval currently serves as chief commercial officer for Alder Biopharmaceuticals, and previously was chief commercial officer at Kythera Biopharmaceuticals, and VP of global strategic marketing at Allergan.
“We are extremely pleased to have Ann and Elisabeth join the ALASTIN team,” said Diane S. Goostree, president and CEO of ALASTIN Skincare. “They bring a wealth of experience related to financial and commercialization strategies within the healthcare and aesthetics space and will be valuable advisors to us as we continue our rapid growth and evolution in the aesthetics field.”
